Clinical Trial Update: Efficacy, Safety, Tolerability of Pegaptanib Sodium (Macugen) in Filipino Patients With Neovascular Age Related Macular Degeneration.

View source ↗

Summary

The document notes a trial evaluating pegaptanib sodium (Macugen) for neovascular age-related macular degeneration in Filipino patients, focusing on efficacy, s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neovascular Age-related Macular Degeneration

Drugs mentioned

• Macugen (pegaptanib sodium)

Snippet

Sponsor: Pfizer | Conditions: Neovascular Age-related Macular Degeneration | Status: WITHDRAWN